Core E: Cell sorting, CyTOF and RNA-Seq
Core E: Cell sorting, CyTOF and RNA-Seq
批准号:
10188604
负责人:
Klaus F. Ley
金额:
$54.45万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-05-31
关键词:
AliquotAllelesAntibodiesAntigen-Presenting CellsAntigensArterial Fatty StreakArteriesAtherosclerosisB-LymphocytesBLR1 geneBioinformaticsBiologicalBone MarrowCD4 Positive T LymphocytesCXCR4 geneCaliforniaCell CommunicationCell SeparationCell surfaceCellsCytometryDNADataData AnalysesDimensionsEnsureFlow CytometryFreezingGenesGenomeGenomicsGreater sac of peritoneumHLA AntigensHandHarvestHumanImmuneIn VitroIndividualInstitutesLanthanoid Series ElementsLeukocytesLibrariesLiquid substanceMapsMemoryMethodsModernizationMonoclonal AntibodiesMusNational Heart, Lung, and Blood InstituteNitrogenNucleotidesPathway AnalysisPatientsPerformancePeripheral Blood Mononuclear CellPeritonealPhenotypePlasmaPopulationPreparationPrincipal Component AnalysisProteinsQuality ControlRNARare Earth MetalsRunningSamplingShippingShipsSpleenT-LymphocyteTechnologyTimeTissuesTrans-Omics for Precision MedicineTubeUniversitiesVirginiaantibody conjugatebasecell typedata qualitydesigndifferential expressiondimensional analysisexperienceexperimental studygenome-widehigh dimensionalityhuman RNA sequencinghuman datahuman leukocyte antigen testingin vivoinstrumentmacrophagemass spectrometermonocytenovelpreservationterminally differentiated effector memory (TEM) T cellstooltranscription factortranscriptometranscriptome sequencingtrizolvapor
中文摘要
Core E描述
核心E有四个功能,服务于所有四个项目。首先,人类和小鼠的T细胞、B细胞和单核细胞将被
从外周血单核细胞(PBMC)中分选并分选到Trizol中,提取RNA,质量控制
(生物分析仪,Agilent TapeStation),制备文库并进行RNA-Seq,以获得约5000 - 7000万
Illumina读取每个样品。初步数据显示,即使在长时间的测序中,
足月冷冻PBMC。小鼠和人类样本集中于项目1的单核细胞亚群,
人和分选小鼠巨噬细胞从腹腔、脾和骨髓中投射2、B1细胞
在野生型、Cxcr 4-/-和Cxcr 5-/-小鼠中,对于项目3,和右旋糖酐高、右旋糖酐低、右旋糖酐阴性效应子
记忆(TEM)细胞和幼稚CD 4 T细胞用于项目4。第二,36至42参数质谱细胞仪(CyTOF)
随后的高维分析(SPADE,viSNE)将用于无监督聚类。我们有
已经获得或结合,滴定和验证了100多个单克隆抗体,开发了一个
一个为所有项目服务的人工小组和四个分别为每个项目服务的人工小组。我们将使用
每个试管中约有100万个细胞,其余约700万个细胞将用于RNA-Seq。
我们还将在小鼠上运行CyTOF。CyTOF识别了已知的细胞类型,并可能提示新的未知细胞类型。
细胞类型(单核细胞、B细胞、T细胞的新亚群)。第三,分选的T细胞和抗原呈递细胞
(APC)将被分配到项目4,并将分选的单核细胞分配到项目1,用于体内功能实验,
如项目中详细说明的那样。最后,核心E还将提供基本的生物信息学支持。这包括
RNA-Seq测序后质量控制、作图读数、差异表达(DE)、热图、Venn
图和主成分分析(PCA)。
英文摘要
Core E description
Core E has four functions, serving all 4 projects. First, human and mouse T cells, B cells and monocytes will be
sorted from peripheral blood mononuclear cells (PBMCs) and sorted into trizol, RNA extracted, quality controls
(bioanalyzer, Agilent TapeStation) performed, libraries prepared and RNA-Seq done to obtain ~50-70 million
Illumina reads per sample. Preliminary data show excellent sequencing depth and data quality even in long-
term frozen PBMCs. Mouse and human samples are focused on monocyte subsets for project 1, treated
human and sorted mouse macrophages for project 2, B1 cells from peritoneal cavity, spleen and bone marrow
in wild-type, Cxcr4-/- and Cxcr5-/- mice for project 3, and dextramerhigh, dextramerlow, dextramernegative effector
memory (TEM) cells and naïve CD4 T cells for project 4. Second, 36 to 42-parameter mass cytometry (CyTOF)
followed by high-dimensional analysis (SPADE, viSNE) will be used for unsupervised clustering. We have
already acquired or conjugated, titrated and validated more than 100 monoclonal antibodies, developed one
human panel that will serve all projects and four human panels that serve each project individually. We will use
about 1 million cells from each tube for this, and the remaining about 7 million cells will be used for RNA-Seq.
We also will run CyTOF on mouse. CyTOF identifies the known cell types and likely will suggest new, unknown
cell types (new subsets of monocytes, B cells, T cells). Third, sorted T cells and antigen presenting cells
(APCs) will be distributed to project 4 and sorted monocytes to project 1 for functional experiments in vivo and
in vitro as detailed in the projects. Finally, core E will also provide basic bioinformatics support. This includes
post-sequencing quality controls for RNA-Seq, mapping reads, differential expression (DE), heat maps, Venn
diagrams and principal component analysis (PCA).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10676897
-
项目类别:
-
资助金额:$54.92万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10229369
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10112954
-
项目类别:
-
资助金额:$90.72万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10369710
-
项目类别:
-
资助金额:$58.9万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:9895858
-
项目类别:
-
资助金额:$90.7万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10623034
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10565907
-
项目类别:
-
资助金额:$76.97万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Core B: Single Cell Protein and RNA Sequencing Core
-
批准号:10334092
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Super-resolution confocal microscope
-
批准号:9274885
-
项目类别:
-
资助金额:$56.63万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosis
-
批准号:10334097
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
ApoB-specific CD4 T cells in mouse and human atherosclerosis
-
批准号:10188608
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8819012
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8966694
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
VASCULATA 2013: Vascular Immunology
-
批准号:8597858
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2013
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8675936
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions in atherosclerosis
-
批准号:9311933
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8346057
-
项目类别:
-
资助金额:$56.61万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8499418
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:9065736
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Cell Phenotyping Core
-
批准号:8703257
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2008
-
负责人:Klaus F. Ley
-
依托单位:
海外基金